Literature DB >> 33391261

The T Cell Receptor Immune Repertoire Protects the Liver From Reconsitution.

Qing Liang1, Yudi Hu1, Meina Zhang1, Chunjie Lin2, Wei Zhang3, Ying Li4, Ping Zhu5, Pengxin Xue1, Yujie Chen1, Qiyuan Li1, Kejia Wang1.   

Abstract

Aberrant immune cell infiltrates and microcircumstances represent characteristic features of liver fibrosis. In this study, we profiled the transcriptomes of intrahepatic CD45+ immune cells, from mice, using single-cell RNA sequencing (scRNA-seq) technology to understand the landscape of intrahepatic immune cells during the pathogenesis of fibrosis. Analysis of approximately 10,000 single-cell transcriptomes revealed an increase in dendritic cells (DCs), macrophages, and neutrophils and a decrease in T and natural killer T (NKT) cells. In addition, we report changes in the transcriptomes of diverse immune cell types, implying a deteriorating intrahepatic immune microcircumstance. Furthermore, we uncovered a novel fibrosis-associated CD8 T (Ccl5 +, Ccl4 +) and CD4 T (mt-Co1 +) cell subpopulation, which infiltrates fibrotic liver and is characterized by abnormal activation or inactivation as well as a TCR decline. The results from scRNA-seq and bulk immune repertoire sequencing (IR-seq) revealed an obvious decline in T cell receptor (TCR) clonotypes combined with shrinking VJ and VDJ segment usage, as well as lower complementarity-determining region 3 (CDR3) amino acid (AA) diversity from fibrotic liver. Interestingly, a deficiency of TCR IR (TcrbKO mice) led to a deterioration of liver fibrosis, coupled with activation of hepatic stellate cells (HSCs) induced by the upregulation of macrophage and γδ T cell distribution in fibrotic TcrbKO livers. Our findings reveal the landscape and dynamics of single immune cells in liver fibrosis, and clarify the protective role of TCR IR in response to chronic liver injury.
Copyright © 2020 Liang, Hu, Zhang, Lin, Zhang, Li, Zhu, Xue, Chen, Li and Wang.

Entities:  

Keywords:  T cell receptor; immune repertoire; intrahepatic immune microcircumstance; liver fibrosis; mass cytometry

Mesh:

Substances:

Year:  2020        PMID: 33391261      PMCID: PMC7775400          DOI: 10.3389/fimmu.2020.584979

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  48 in total

Review 1.  Liver: An organ with predominant innate immunity.

Authors:  Bin Gao; Won-Il Jeong; Zhigang Tian
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

Review 2.  Mechanisms of hepatic fibrogenesis.

Authors:  Scott L Friedman
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

3.  High-throughput T cell receptor sequencing reveals distinct repertoires between tumor and adjacent non-tumor tissues in HBV-associated HCC.

Authors:  Yunqing Chen; Ying Xu; Miaoxian Zhao; Yu Liu; Mingxing Gong; Cantao Xie; Hongkai Wu; Zhanhui Wang
Journal:  Oncoimmunology       Date:  2016-08-05       Impact factor: 8.110

Review 4.  Schistosome-Induced Fibrotic Disease: The Role of Hepatic Stellate Cells.

Authors:  Jack P Carson; Grant A Ramm; Mark W Robinson; Donald P McManus; Geoffrey N Gobert
Journal:  Trends Parasitol       Date:  2018-03-08

5.  High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires.

Authors:  Evaggelia Liaskou; Eva Kristine Klemsdal Henriksen; Kristian Holm; Fatemeh Kaveh; David Hamm; Janine Fear; Marte K Viken; Johannes Roksund Hov; Espen Melum; Harlan Robins; Johanna Olweus; Tom H Karlsen; Gideon M Hirschfield
Journal:  Hepatology       Date:  2015-09-30       Impact factor: 17.425

6.  Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride.

Authors:  Ogyi Park; Won-Il Jeong; Lei Wang; Hua Wang; Zhe-Xiong Lian; M Eric Gershwin; Bin Gao
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

7.  Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway.

Authors:  Ronald Charles; Hong-Shiue Chou; Lianfu Wang; John J Fung; Lina Lu; Shiguang Qian
Journal:  Transplantation       Date:  2013-07-15       Impact factor: 4.939

Review 8.  Hepatic stellate cells as key target in liver fibrosis.

Authors:  Takaaki Higashi; Scott L Friedman; Yujin Hoshida
Journal:  Adv Drug Deliv Rev       Date:  2017-05-12       Impact factor: 17.873

9.  Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis.

Authors:  Ali A Mokdad; Alan D Lopez; Saied Shahraz; Rafael Lozano; Ali H Mokdad; Jeff Stanaway; Christopher J L Murray; Mohsen Naghavi
Journal:  BMC Med       Date:  2014-09-18       Impact factor: 8.775

10.  Analysis of the complementarity determining regions β-chain genomic rearrangement using high-throughput sequencing in periphery cytotoxic T lymphocytes of patients with chronic hepatitis B.

Authors:  Yinuo Huang; Hong Ma; Shutang Wei; Gang Luo; Ruimin Sun; Zhibo Fan; Liping Wu; Wenyi Yang; Lin Fu; Junhui Wang; Dazheng Han; Jun Lu
Journal:  Mol Med Rep       Date:  2016-05-23       Impact factor: 2.952

View more
  4 in total

Review 1.  Targeting fibrosis, mechanisms and cilinical trials.

Authors:  Manyu Zhao; Liqun Wang; Mengzhu Wang; Shijie Zhou; Ying Lu; Huijie Cui; Alexandra C Racanelli; Ling Zhang; Tinghong Ye; Bisen Ding; Ben Zhang; Jinliang Yang; Yuqin Yao
Journal:  Signal Transduct Target Ther       Date:  2022-06-30

Review 2.  CD4+ T cell activation and inflammation in NASH-related fibrosis.

Authors:  Yunfeng Zhou; Haibo Zhang; Yao Yao; Xiaoyan Zhang; Youfei Guan; Feng Zheng
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

Review 3.  Research progress on application of single-cell TCR/BCR sequencing technology to the tumor immune microenvironment, autoimmune diseases, and infectious diseases.

Authors:  Jinhua He; Jian Shen; Wenfeng Luo; Zeping Han; Fangmei Xie; Ting Pang; Liyin Liao; Zhonghui Guo; Jianhao Li; Yuguang Li; Hanwei Chen
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

Review 4.  The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis.

Authors:  Jingjing Li; Chuanyong Guo; Jianye Wu
Journal:  Drug Des Devel Ther       Date:  2021-06-18       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.